NLRP3 and atherosclerosis: NLRP3‐dependent inflammation is suggested to drive neuroinflammation in neurodegenerative conditions including Alzheimer's and Parkinson's disease in addition to peripheral diseases such as atherosclerosis, type‐2 diabetes, and others (Wang et al., 2020).